Global Asthma & COPD Drugs Market By Disease (Asthma, Chronic Obstructive Pulmonary Disease), By Medication Class(Long term asthma control medications, Quick Relief medications), By Route of Administration (Oral, Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: March 2024
- Report ID: 117138
- Number of Pages: 214
- Format:
-
keyboard_arrow_up
-
-
- GlaxoSmithKline Plc.
- AstraZeneca Plc.
- Novartis AG Company Profile
- Merck and Co Inc.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Sanofi Company Profile
- Suvonion Pharmaceuticals, Inc.
- Roche Holdings AG
- Vectura Group
- Pfizer Inc Company Profile
- settingsSettings
Our Clients
- 117138
- March 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
